Clinical Trials
232 trialsNCT00001186 2026-06-05
Psychological Benefits of a Normalized Camping Experience for Children With Cancer
National Institutes of Health Clinical Center (CC)
Recruiting
NCT00026650 2026-06-05
Evaluation of Late Effects and Natural History of Disease in Patients Treated With Radiotherapy
National Institutes of Health Clinical Center (CC)
Recruiting
NCT03366116 2026-06-05
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Recruiting
NCT04585958 2026-06-05
Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer
National Cancer Institute (NCI)
Phase 1 Recruiting
NCT05232409 2026-06-05
Determine Safety & Recommended Phase 2 Dosing of Zeaxanthin Alone or in Combination w/Pembrolizumab in Patients With Metastatic Cancer
Valley Health System
Phase 1 Recruiting
NCT05294302 2026-06-05
Testing eSCCIP: An eHealth Psychosocial Intervention for English and Spanish Speaking Parents of Children With Cancer
Nemours Children's Clinic
Phase NA Recruiting
NCT06178614 2026-06-05
A Study of JNJ-87890387 for Advanced Solid Tumors
Janssen Research & Development, LLC
Phase 1 Recruiting
NCT06311578 2026-06-05
A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors
Johnson & Johnson Enterprise Innovation Inc.
Phase 1 Recruiting
NCT06901531 2026-06-05
LUCERNA
Astellas Pharma Inc
Phase 3 Recruiting
NCT07005102 2026-06-05
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
AbbVie
Phase 2/3 Recruiting
NCT07525141 2026-06-05
A Study of JNJ-1761981 in Participants With Solid Tumors
Johnson & Johnson Enterprise Innovation Inc.
Phase 1 Recruiting
NCT01518400 2026-06-04
LIFE Cancer Survivorship Database for Pediatric Cancer
Children's Hospital Los Angeles
Recruiting
NCT04621435 2026-06-04
Imaging of Solid Tumors Using FAP-2286
University of California, San Francisco
Phase 1 Recruiting
NCT05004116 2026-06-04
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Memorial Sloan Kettering Cancer Center
Phase 1/2 Recruiting
NCT05350761 2026-06-04
Rare Tumors and Cancer Predisposition in Individuals and Families
National Institutes of Health Clinical Center (CC)
Recruiting
NCT07390435 2026-06-04
FACTOR
Canadian Cancer Trials Group
Recruiting
NCT07403721 2026-06-04
AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors
Amgen
Phase 1 Recruiting
NCT03899155 2026-06-03
Pan Tumor Rollover Study
Bristol-Myers Squibb
Phase 2 Recruiting
NCT05120518 2026-06-03
Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells
Ann & Robert H Lurie Children's Hospital of Chicago
Recruiting
NCT06055296 2026-06-03
COMPRENDO
University of California, San Diego
Phase NA Recruiting
NCT07086768 2026-06-03
Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in Patients With Advanced or Metastatic Solid Tumors
The University of Texas Health Science Center at San Antonio
Phase 1 Recruiting
NCT07178847 2026-06-03
NeckTAR-IN
Centre Jean Perrin
Phase NA Recruiting
NCT07197671 2026-06-03
Y-NM600 in Patients Receiving Anti-PD-1 or Anti-PD-L1 for Metastatic Cancer
University of Wisconsin, Madison
Phase 1 Recruiting
NCT07247110 2026-06-03
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
Merck Sharp & Dohme LLC
Phase 1 Recruiting
NCT07622667 2026-06-03
Correlation Analysis of Gene Characteristics of Malignant Tumors With Prognosis
Nanfang Hospital, Southern Medical University
Recruiting
NCT03435796 2026-06-02
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Celgene
Phase 2/3 Recruiting
NCT04242095 2026-06-02
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Alliance for Clinical Trials in Oncology
Recruiting
NCT03370406 2026-06-01
Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC
University of Pittsburgh
Phase 1 Recruiting
NCT04609072 2026-06-01
Connect for Cancer Prevention Study (Connect)
National Institutes of Health Clinical Center (CC)
Recruiting
NCT05539794 2026-06-01
EXERCADOL
Universidad Europea de Madrid
Phase NA Recruiting
NCT07213817 2026-06-01
A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours
Ipsen
Phase 1/2 Recruiting
NCT07213830 2026-06-01
A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies
Ipsen
Phase 1/2 Recruiting
NCT03245411 2026-05-29
Assessment of Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients
Thomas Jefferson University
Phase NA Recruiting
NCT04145622 2026-05-29
Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors
Daiichi Sankyo
Phase 1/2 Recruiting
NCT04934293 2026-05-29
REVER
Centre Antoine Lacassagne
Phase NA Recruiting
NCT06851975 2026-05-29
BEST
Centre Antoine Lacassagne
Phase NA Recruiting
NCT04207437 2026-05-28
Daily Hand-Held Vibration Therapy
Indiana University
Phase NA Recruiting
NCT05365581 2026-05-28
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
Astellas Pharma Inc
Phase 1 Recruiting
NCT06952790 2026-05-28
FOCUS
University of Miami
Phase NA Recruiting
NCT07335497 2026-05-28
ASCEND
Crescent Biopharma, Inc.
Phase 1/2 Recruiting
NCT07404332 2026-05-28
5-Azacitidine Plus PD-1/PD-L1 Inhibitor With PD-1/PD-L1 Refractory Tumors
University of Iowa
Phase 1 Recruiting
NCT07612176 2026-05-28
A Phase 1 Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
NEOK Bio, Inc.
Phase 1 Recruiting
NCT03089554 2026-05-27
Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
University of Kentucky
Phase 2 Recruiting
NCT03180918 2026-05-27
Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment
University Hospital, Geneva
Phase NA Recruiting
NCT05384626 2026-05-27
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Nuvalent Inc.
Phase 1/2 Recruiting
NCT06311214 2026-05-27
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
National Cancer Institute (NCI)
Phase 2 Recruiting
NCT07438782 2026-05-27
First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors
GlaxoSmithKline
Phase 1 Recruiting
NCT05195710 2026-05-26
Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver Metastases
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT06799819 2026-05-26
MOBITEP
Centre Hospitalier Régional d'Orléans
Phase NA Recruiting
NCT07080333 2026-05-26
MICROBLADDERK
Centre Hospitalier Universitaire de Nice
Phase NA Recruiting